Analysis performed using the UCSC Xena platform (https://xena.ucsc.edu/compare-tissue/), based on data from the TCGA Breast Cancer (BRCA) cohort and accessed on 28 March 2025, revealed no significant differences in overall survival based on PAX6 expression levels (Figure 1C). The gene discussed is PAX6; the disease is breast cancer.